While AR and GR transcriptional output presents a considerable overlap, GR activation leads to an attenuation of AR-dependent transcriptional programs, hence a partial antiandrogen effect, suggesting the tumor suppressor role of GR in prostate cancer [105, 149]. This evidence concerns the gene NR3C1 and prostate carcinoma.